All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for AMERICA'S HEALTH INSURANCE PLANS

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income · posted Jul 17, 2026

Official filing document

Bills named in this filing 2

S 1105
No UPCODE Act
HR 247
Health Care Affordability Act of 2025

Lobbying activity 4

Health Issues

Issues related to the accessibility and affordability of healthcare, surprise medical billing.

Medicare/Medicaid

Issues related to Medicare and Medicaid payments and the Medicare Advantage Prescription Drug Pricing program. S.1105 - No UPCODE Act CY 2027 Medicare Advantage Rate Notice.

Taxation/Internal Revenue Code

ACA premium tax credits. Issues related to FSA's, HSA's and ICHRA's. H.R. 247 - Healthcare Affordability Act.

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.